What does ARGENX SE do?

ARGENX SE is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in P7. It is registered with the SEC under CIK 0001697862 and trades on NASDAQ under the ticker ARGX.

How many SEC filings has ARGENX SE made?

ARGENX SE has filed 269 documents with the SEC since 2017. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

ARGENX SE

ARGX NASDAQ CIK: 0001697862 Biological Products, (No Diagnostic Substances) Inc. in P7

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 269 filings →

Form	Description	Date
6-K	FORM 6-K	Mar 20, 2026
20-F	20-F	Mar 19, 2026
6-K	6-K	Mar 19, 2026
6-K	FORM 6-K	Mar 6, 2026
6-K	6-K	Feb 26, 2026
6-K	FORM 6-K	Feb 26, 2026
6-K	FORM 6-K	Jan 13, 2026
6-K	FORM 6-K	Jan 12, 2026
6-K	FORM 6-K	Jan 5, 2026
S-8	FORM S-8	Dec 17, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for ARGENX SE. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001697862
Ticker: ARGX
Exchange: NASDAQ
Incorporated: P7
First Filing: 2017
Total Filings: 269

Biological Products, (No Diagnostic Substances) rankings →